Skip to content

Effect of Bi-flow mode with flow monitoring in patients with mild to moderate respiratory failure

Effect of Bi-flow mode with flow monitoring in patients with mild to moderate respiratory failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009734
Enrollment
60
Registered
2024-08-29
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Observation and inspection methods - Baseline After obtaining a written consent form from the subject and agent who show intention to participate, the following procedure is performed

Sponsors

MEKICS
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients who are 18 years of age or older and have agreed to participate in the study through themselves and their representatives (2) Patients in hospital with hypoxic respiratory failure who need high-flow nasal cannula treatment Definition of hypoxic respiratory failure : mild /moderate respiratory failure (100mmHg < PaO2/FiO2 ratio =300mmHg)

Exclusion criteria

Exclusion criteria: (1) Patients who have difficulty applying the nasal cannula due to previous facial surgery, trauma, deformity, airway obstruction, etc (2) Patients who need mechanical ventilation due to unclear level of consciousness or progressive respiratory failure (3) Patients whose PIF measurements are inaccurate due to L-tube insertion

Design outcomes

Primary

MeasureTime frame
Oxygenation and Co2 changes during the initial 72 hours

Secondary

MeasureTime frame
Changes in ROX index (SpO2/FiO2 ratio/respiratory rate) during one week / Biomarkers of patients (pulse rate, respiratory rate, SpO2, blood pressure) / Modified Borg scale / HFNC duration and HFNC failure rate.

Countries

Korea, Republic of

Contacts

Public ContactHan Na Moon

Asan Medical Center

qpsxm012@naver.com+82-2-3010-5454

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026